HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A new role for cathelicidin in ulcerative colitis in mice.

Abstract
Cathelicidin, an antimicrobial peptide of the innate immune system, modulates microbial growth, wound healing, and inflammation. However, its association with inflammatory bowel diseases (IBDs) is unknown. Our objective was to determine whether cathelicidin would exert a modulatory effect on the progression of IBD and, if so, investigate the mechanism of action through which this effect occurred. We evaluated the potential for a synthetic cathelicidin, the mouse cathelin-related antimicrobial peptide (mCRAMP), to prevent the initiation and promote the healing of lesions from inflammatory colitis that was experimentally induced in mice with dextran sulfate sodium (DSS). During the experiment, mCRAMP was given: (i) as a parallel treatment starting together with 3% DSS feeding, and (ii) as a posttreatment starting 7 days after 3% DSS feeding. The body weight, fecal microflora populations, clinical symptoms, and histologic findings of colonic tissues were measured. Relative gene expression of mucins (MUC1, MUC2, MUC3, and MUC4) in colonic tissues was determined by real-time polymerase chain reaction. Intrarectal administration of mCRAMP ameliorated DSS-induced colitis with negligible effects on mucosal healing. The peptide also significantly reduced the increased number of fecal microflora in colitis animals. It reversed the decline of colonic mucus thickness during colitis through upregulation of the expression of mucin genes. Treatment with mCRAMP also prevented colitis development by suppressing the induction of apoptosis by DSS. The current study demonstrates for the first time that intrarectal administration of cathelicidin may be a novel therapeutic option for IBDs.
AuthorsEmily K K Tai, William K K Wu, Helen P S Wong, Emily K Y Lam, L Yu, C H Cho
JournalExperimental biology and medicine (Maywood, N.J.) (Exp Biol Med (Maywood)) Vol. 232 Issue 6 Pg. 799-808 (Jun 2007) ISSN: 1535-3702 [Print] England
PMID17526772 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Bacterial Agents
  • Antimicrobial Cationic Peptides
  • Cathelicidins
  • Mucins
  • Dextran Sulfate
  • Peroxidase
Topics
  • Administration, Rectal
  • Animals
  • Anti-Bacterial Agents (pharmacology)
  • Antimicrobial Cationic Peptides (pharmacology)
  • Apoptosis (drug effects)
  • Cathelicidins
  • Colitis, Ulcerative (chemically induced, metabolism, pathology, prevention & control)
  • Colon (drug effects, metabolism, pathology)
  • Dextran Sulfate
  • Feces (microbiology)
  • Gene Expression (drug effects)
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Mucins (genetics)
  • Mucus (metabolism)
  • Peroxidase (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: